TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04752774: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Sponsor: Ipsen · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 240 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,172,940

Rescue Site Savings

+$1,439,220

Unlock Full NCT04752774 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04752774 Rescue Dossier →